Clinical trial Recruiting at 1 site Interventional Ages 21 to 85

Neuromodulation effects on laryngeal dystonia

Official title: The Effects of Neuromodulation on Phonatory Function in Laryngeal Dystonia

Run by MGH Institute of Health Professions · NCT05095740 · Data updated 2026-11-12

This study is testing if a brain stimulation treatment can help people with laryngeal dystonia improve their voice and overall quality of life.

Quick facts

Study typeInterventional
Ages21 Years to 85 Years
SexAll
Enrollment25 (estimated)
SponsorMGH Institute of Health Professions
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedJune 10, 2021
Main results expectedDecember 31, 2026
Study endsDecember 31, 2026
Registry record updatedFebruary 20, 2026
Trial IDNCT05095740 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 21-85 who have been diagnosed with laryngeal dystonia and are experiencing severe symptoms.

Probably not a fit

Patients with other forms of dystonia, vocal fold pathology, or those who have had laryngeal surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of repetitive transcranial magnetic stimulation (rTMS) on individuals diagnosed with laryngeal dystonia, a condition that severely impacts voice quality and quality of life. The research aims to understand the cortical excitability and inhibition of laryngeal muscles, which may provide insights into the pathophysiology of the disorder. By comparing brain activity patterns in patients with laryngeal dystonia to those with limb dystonia, the study seeks to identify potential novel interventions for this challenging condition. Participants will receive either active rTMS or sham treatment to evaluate the efficacy of this approach.

Why it matters

Potential benefit: If successful, this study could lead to new, effective treatments for laryngeal dystonia, improving voice quality and overall quality of life for patients.

How similar studies have gone: While similar approaches using TMS have been successful in limb dystonia, this application in laryngeal dystonia is novel and has not been previously tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age range is 21-85 years
* Diagnosis of Laryngeal Dystonia (LD)
* Subject is able to give informed consent
* Symptoms at worst severity if receiving botulinum toxin injections
* Subject has signed the consent form

Exclusion Criteria:

* Other forms of dystonia
* Vocal fold pathology or paralysis
* Essential tremor
* Laryngeal cancer or other neurologic conditions with medications affecting the central nervous system
* History of laryngeal surgery
* Adults lacking the ability to consent or complete the assessments and intervention
* Seizure in the last 2 years
* Contraindications to rTMS

Where it's running

  • Teresa J Kimberley
    Boston, Massachusetts, United States
    Recruiting

Study contacts

  • Principal investigator: Teresa J Kimberley, PhD,PT — MGH Institute of Health Professions
  • Study coordinator: Caitlin Koehler, Lab Manager
  • Email: brainrecoverylab@mghihp.edu
  • Phone: 617-643-6564

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.